RecruitingNCT06816303
Patients With Diabetes Mellitus on Drug Treatment on the List or Already Undergoing Orthotopic Liver Transplantation
Adult Patients With Diabetes Mellitus, on Drug Treatment, on the List or Already Undergoing Orthotopic Liver Transplantation: an Observational Study
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
100 participants
Start Date
Nov 19, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
observational study through which we aim to collect information on metabolic compensation, the degree of satisfaction with hypoglycemic therapy, the onset of complications of diabetes or liver disease, evaluation of survival, in patients on the list for at least three months or already undergoing liver transplantation for at least three months
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- type 2 diabetes mellitus
- presence on the list for OLT for at least 3 months or have already been submitted to OLT for at least 3 months
- age ≥ 18 years
- signature of written informed consent to participate in the observational study, either by the participant or legal guardian
Exclusion Criteria1
- \- Pregnancy or breastfeeding
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06816303
Related Trials
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
NCT06112418115 locations
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT070644731153 locations
Project Dulce for Arab Americans With Type 2 Diabetes
NCT055805362 locations
The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination
NCT038787061 location
Improving Health Outcomes With Kefir
NCT066952211 location